Immatics N.V. Ordinary Shares

IMTXNASDAQUSD
10.31 USD
0.04 (0.39%)AT CLOSE (11:59 AM EDT)
10.32
0.01 (0.05%)
POST MARKET (AS OF 05:24 PM EDT)
Post Market
AS OF 05:24 PM EDT
10.32
0.01 (0.05%)
🟢Market: OPEN
Open?$10.42
High?$10.64
Low?$10.21
Prev. Close?$10.35
Volume?368.5K
Avg. Volume?N/A
VWAP?$10.40
Bid / Ask
Bid?$8.82 × 100
Ask?$11.69 × 100
Spread?$2.87
Midpoint?$10.25
Valuation & Ratios
Market Cap?1.4B
Shares Out?134.1M
Float?91.6M
Float %?75.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Employees
407
Market Cap
1.4B
Industry
N/A
Listed
2020-07-02